Show simple item record

dc.contributor.authorSolomon, Nadia
dc.contributor.authorZeyhle, Eberhard
dc.contributor.authorCarter, Jane
dc.contributor.authorWachira, John
dc.contributor.authorMengiste, Asrat
dc.contributor.authorRomig, Thomas
dc.contributor.authorFields, Paul J.
dc.contributor.authorMacpherson, Calum N. L.
dc.date.accessioned2021-08-19T20:23:27Z
dc.date.available2021-08-19T20:23:27Z
dc.date.issued5/30/2017
dc.identifier.citationAm. J. Trop. Med. Hyg., 97(2), 2017, pp. 587–595 doi:10.4269/ajtmh.16-0643en_US
dc.identifier.urihttp://repository.amref.org/handle/123456789/102
dc.descriptionAm. J. Trop. Med. Hyg., 97(2), 2017, pp. 587–595 doi:10.4269/ajtmh.16-0643 Copyright © 2017 by The American Society of Tropical Medicine and Hygieneen_US
dc.description.abstractCystic echinococcosis (CE) is a neglected zoonotic disease caused by Echinococcus granulosus. Infection leads to formation of cysts within the viscera of the human host. In the 1980s, the transhumant population of northwest Turkana, Kenya, was found to have the highest prevalence of CE in the world. In 1983, AMREF Health Africa and the Kenya Medical and Research Institute launched a CE Control Program in northwest Turkana, screening and treating the local people. This epidemiological study of CE in Turkana analyses approximately 30 years of surveillance and surgical data. Cyst data were categorized using the World Health Organization CE ultrasound classification system before being analyzed for cyst, patient, and population characteristics, and surveillance data from 1985 are compared with more recent surveillance data to assess changes in prevalence in the control region since the commencement of control activities. In 1985, the prevalence of CE among the Turkana was 5.6%. In 2010–2011 and 2011–2012, calculated CE prevalence rates were 1.9% and 3.8%, respectively. Since the 1980s, the age distribution of people with CE in Turkana has shifted: initially, cases of CE appeared predominantly within younger age groups, but recent data reveal a higher prevalence within older age groups. The frequency of infection in females also significantly decreased. The reduction in CE prevalence from 5.6% in the 1980s to 1.9–3.8% in 2010–2012 and the shift in age distribution of CE-infected individuals over time indicate that the prevalence of CE in Turkana has decreased since the control program began.en_US
dc.description.sponsorshipAmref Health Africa (formerly the African Medical and Research Foundation), the Kenya Medical Research Institute (KEMRI), the Deutsche Forschungsgemeinschaft (DFG), and the Cystic Echinococcosis in SubSaharan Africa Researchen_US
dc.language.isoenen_US
dc.publisherThe American Society of Tropical Medicine and Hygieneen_US
dc.subjectCystic Echinococcosisen_US
dc.subjectCross-sectional Screening Surveysen_US
dc.subjectInfectionen_US
dc.subjectCysten_US
dc.subjectTurkanaen_US
dc.subjectKenyaen_US
dc.titleCystic Echinococcosis in Turkana, Kenya: The Role of Cross-Sectional Screening Surveys in Assessing the Prevalence of Human Infectionen_US
dc.typeArticle, Journalen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • General - GEN [353]
    This is a collection of research papers from the wider Amref community

Show simple item record